EFFECTS OF GLYCOLYTIC INHIBITOR ON THE METABOLIC PHENOTYPE, CELL PROLIFERATION AND APOPTOSIS OF HUMAN ESOPHAGEAL CANCER CELLS

(1) The First Hospital Affiliated to Nanjing Medical University

(2) The Zhangjiagang Hospital Affiliated to Soochow University



This item was part of the Oesophageal, Gastric and Duodenal Disorders III session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A380